BARICITINIB

BARICITINIB was reported 3052 times

BARICITINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HAEMOGLOBIN C DISEASE 3 0.7500
1 ACINIC CELL CARCINOMA OF SALIVARY GLAND 5 0.5000
2 LUMBOSACRAL PLEXOPATHY 26 0.3023
3 MITRAL PERFORATION 4 0.2500
4 PERINEAL RASH 25 0.2033
5 STAPHYLOCOCCAL PAROTITIS 2 0.1818
6 CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE 8 0.1455
7 TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME 7 0.1167
8 NEUROLYSIS 3 0.0909
9 CUTANEOUS T-CELL LYMPHOMA STAGE IV 3 0.0833
10 TESTICULAR SEMINOMA (PURE) 8 0.0672
11 FEBRILE INFECTION-RELATED EPILEPSY SYNDROME 2 0.0645
12 SPINAL CORD INJURY CERVICAL 16 0.0635
13 VEXAS SYNDROME 6 0.0625
14 CUTANEOUS MALACOPLAKIA 3 0.0588
15 NEPHRITIS BACTERIAL 2 0.0526
16 AUTOINFLAMMATORY DISEASE 11 0.0519
17 TENDER JOINT COUNT INCREASED 4 0.0494
18 PARAINFLUENZA VIRUS INFECTION 5 0.0485
19 BLOOD FOLATE DECREASED 35 0.0481
20 ULTRASOUND DOPPLER ABNORMAL 8 0.0462
21 SPINAL CLAUDICATION 5 0.0424
22 IATROGENIC KAPOSI SARCOMA 2 0.0408
23 SPLEEN TUBERCULOSIS 2 0.0392
24 CHROMOBLASTOMYCOSIS 3 0.0353
25 SINUSITIS ASPERGILLUS 5 0.0316
26 CITROBACTER TEST POSITIVE 2 0.0303
27 STENOTROPHOMONAS TEST POSITIVE 4 0.0299
28 DRUG HALF-LIFE INCREASED 3 0.0263
29 DIVERTICULITIS INTESTINAL PERFORATED 9 0.0252
30 PERIPHERAL VEIN THROMBOSIS 6 0.0251
31 APPENDICEAL ABSCESS 6 0.0247
32 GEOTRICHUM INFECTION 5 0.0237
33 IMMOBILISATION SYNDROME 5 0.0235
34 SPUTUM CULTURE POSITIVE 19 0.0234
35 HERPES SIMPLEX REACTIVATION 8 0.0210
36 SERRATIA TEST POSITIVE 2 0.0206
37 CARDIAC ASTHMA 3 0.0200
38 SPINAL INSTABILITY 5 0.0197
39 PARASPINAL ABSCESS 3 0.0194
40 HERPES ZOSTER INFECTION NEUROLOGICAL 3 0.0189
41 OBSTRUCTIVE SHOCK 2 0.0183
42 SEPTIC ENCEPHALOPATHY 3 0.0174
43 INTESTINAL BARRIER DYSFUNCTION 2 0.0172
44 BONE FISSURE 7 0.0168
45 SYNOVECTOMY 3 0.0164
46 RENAL EMBOLISM 3 0.0162
47 PERIOSTITIS 7 0.0162
48 STOMATOCOCCAL INFECTION 2 0.0161
49 MYCOTIC ENDOPHTHALMITIS 3 0.0159
50 HAEMOPHILUS TEST POSITIVE 2 0.0155
51 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 5 0.0152
52 PNEUMOTHORAX SPONTANEOUS 10 0.0147
53 CUBITAL TUNNEL SYNDROME 5 0.0147
54 GREATER TROCHANTERIC PAIN SYNDROME 3 0.0146
55 GROWTH FAILURE 5 0.0145
56 KERATITIS FUNGAL 3 0.0144
57 ANENCEPHALY 8 0.0142
58 BANDAEMIA 2 0.0136
59 DISSEMINATED ASPERGILLOSIS 6 0.0127
60 POST PROCEDURAL FEVER 3 0.0124
61 POSTICTAL PARALYSIS 3 0.0124
62 NEUROGENIC BLADDER 26 0.0123
63 RENAL VASCULAR THROMBOSIS 2 0.0117
64 DRUG RESISTANCE MUTATION 2 0.0112
65 PNEUMONIA PSEUDOMONAL 17 0.0111
66 INTESTINAL METASTASIS 4 0.0110
67 HERPES ZOSTER MENINGITIS 2 0.0109
68 KLEBSIELLA TEST POSITIVE 7 0.0108
69 AVERSION 3 0.0104
70 POLYOMAVIRUS VIRAEMIA 11 0.0104
71 B-LYMPHOCYTE COUNT DECREASED 14 0.0103
72 STEROID DEPENDENCE 9 0.0103
73 METASTASES TO STOMACH 4 0.0102
74 EXTRAPULMONARY TUBERCULOSIS 3 0.0102
75 PNEUMOMEDIASTINUM 18 0.0100
76 NASAL HERPES 2 0.0099
77 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 72 0.0096
78 GRANULOMA ANNULARE 7 0.0095
79 MECONIUM ASPIRATION SYNDROME 2 0.0095
80 LYMPH NODE TUBERCULOSIS 7 0.0094
81 DISSEMINATED CYTOMEGALOVIRAL INFECTION 2 0.0093
82 VULVITIS 3 0.0091
83 PULMONARY NECROSIS 3 0.0088
84 FIBRIN D DIMER INCREASED 31 0.0087
85 BREAKTHROUGH COVID-19 2 0.0087
86 ECZEMA HERPETICUM 4 0.0086
87 PNEUMONIA STAPHYLOCOCCAL 17 0.0086
88 ERYTHRODERMIC PSORIASIS 7 0.0085
89 ALVEOLAR PROTEINOSIS 5 0.0084
90 METATARSALGIA 2 0.0083
91 HERPES SIMPLEX HEPATITIS 2 0.0083
92 JEJUNAL PERFORATION 2 0.0083
93 ENTEROBACTER TEST POSITIVE 2 0.0081
94 RESPIRATORY TRACT INFECTION BACTERIAL 4 0.0080
95 MUSCLE ABSCESS 5 0.0080
96 KERATOCONUS 3 0.0080
97 CAVERNOUS SINUS THROMBOSIS 2 0.0079
98 OSTEOCHONDROSIS 9 0.0078
99 GASTROINTESTINAL LYMPHOMA 2 0.0077
100 CEREBRAL TOXOPLASMOSIS 7 0.0075
101 HYPEREOSINOPHILIC SYNDROME 4 0.0074
102 STENOTROPHOMONAS INFECTION 10 0.0074
103 CLUBBING 3 0.0074
104 UREAPLASMA INFECTION 3 0.0074
105 LICHENIFICATION 3 0.0073
106 INTERLEUKIN LEVEL INCREASED 4 0.0072
107 CANDIDA TEST POSITIVE 3 0.0072
108 PERIPHERAL ARTERY OCCLUSION 10 0.0071
109 JARISCH-HERXHEIMER REACTION 5 0.0070
110 LEGIONELLA INFECTION 4 0.0070
111 DIFFUSE ALVEOLAR DAMAGE 8 0.0070
112 ROTAVIRUS INFECTION 4 0.0069
113 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 12 0.0068
114 PNEUMOCOCCAL INFECTION 4 0.0068
115 VARICELLA ZOSTER VIRUS INFECTION 14 0.0067
116 CERVICITIS 3 0.0067
117 IDIOPATHIC PNEUMONIA SYNDROME 2 0.0067
118 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 2 0.0067
119 BRONCHIAL HYPERREACTIVITY 8 0.0067
120 TRACHEITIS 5 0.0066
121 STAPHYLOCOCCAL SKIN INFECTION 8 0.0065
122 ASPERGILLUS TEST POSITIVE 2 0.0065
123 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 2 0.0065
124 DEVICE RELATED BACTERAEMIA 2 0.0065
125 CUTANEOUS T-CELL LYMPHOMA 8 0.0063
126 ASPERGILLOMA 2 0.0063
127 PNEUMONIA NECROTISING 4 0.0062
128 ENTEROCOCCUS TEST POSITIVE 4 0.0062
129 INFECTION REACTIVATION 7 0.0061
130 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 8 0.0061
131 HEPATITIS B DNA INCREASED 4 0.0059
132 PARANEOPLASTIC SYNDROME 4 0.0059
133 GLYCOSURIA 8 0.0059
134 CENTRAL NERVOUS SYSTEM VASCULITIS 3 0.0059
135 CHOLESTATIC LIVER INJURY 13 0.0058
136 COVID-19 PNEUMONIA 67 0.0057
137 CYTOMEGALOVIRUS ENTERITIS 2 0.0056
138 ORTHOSTATIC INTOLERANCE 4 0.0056
139 HERPES ZOSTER MENINGOENCEPHALITIS 2 0.0056
140 HYPERPARATHYROIDISM PRIMARY 2 0.0055
141 OBSTRUCTIVE SLEEP APNOEA SYNDROME 8 0.0055
142 PSYCHOGENIC SEIZURE 5 0.0053
143 STAPHYLOCOCCUS TEST POSITIVE 11 0.0052
144 NASAL ULCER 8 0.0050
145 ESCHERICHIA TEST POSITIVE 6 0.0050
146 STRONGYLOIDIASIS 8 0.0049
147 SPLENIC ABSCESS 2 0.0049
148 BRONCHOPULMONARY ASPERGILLOSIS 38 0.0049
149 CERVICOBRACHIAL SYNDROME 3 0.0049
150 CARDIAC VENTRICULAR DISORDER 2 0.0049
151 DIVERTICULAR PERFORATION 10 0.0049
152 POST-ACUTE COVID-19 SYNDROME 6 0.0048
153 STAPHYLOCOCCAL ABSCESS 3 0.0047
154 URGE INCONTINENCE 4 0.0046
155 CHONDROCALCINOSIS 3 0.0046
156 HISTOPLASMOSIS DISSEMINATED 7 0.0044
157 MALACOPLAKIA 2 0.0044
158 PAROTITIS 5 0.0043
159 PNEUMONIA CRYPTOCOCCAL 4 0.0042
160 KLEBSIELLA BACTERAEMIA 4 0.0042
161 BRONCHIAL WALL THICKENING 3 0.0042
162 PNEUMONIA HAEMOPHILUS 2 0.0041
163 IMMUNODEFICIENCY COMMON VARIABLE 2 0.0041
164 DUODENAL PERFORATION 4 0.0041
165 ENDOCARDITIS STAPHYLOCOCCAL 2 0.0041
166 PNEUMONIA PNEUMOCOCCAL 6 0.0040
167 PARATHYROID TUMOUR BENIGN 3 0.0040
168 PNEUMONIA BACTERIAL 37 0.0040
169 PSEUDOMONAL SEPSIS 7 0.0040
170 SEPSIS SYNDROME 2 0.0040
171 PULMONARY ARTERY THROMBOSIS 3 0.0039
172 CEREBRAL ARTERY THROMBOSIS 2 0.0039
173 ENTHESOPATHY 6 0.0038
174 THROMBOCYTOSIS 14 0.0038
175 RESPIRATORY TRACT INFECTION FUNGAL 2 0.0038
176 HERPES ZOSTER DISSEMINATED 3 0.0037
177 PERIODONTITIS 8 0.0037
178 BLOOD CULTURE POSITIVE 11 0.0037
179 PSEUDOMONAS TEST POSITIVE 3 0.0037
180 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 14 0.0037
181 ACINETOBACTER INFECTION 4 0.0037
182 ULCERATIVE KERATITIS 10 0.0036
183 PULMONARY NOCARDIOSIS 3 0.0036
184 EMBOLISM VENOUS 11 0.0036
185 VACCINATION FAILURE 6 0.0036
186 SYSTEMIC CANDIDA 9 0.0036
187 PERIPHERAL ARTERY THROMBOSIS 5 0.0036
188 RETINITIS 6 0.0035
189 ALOPECIA AREATA 6 0.0034
190 GRAFT COMPLICATION 2 0.0034
191 ENDOTRACHEAL INTUBATION COMPLICATION 2 0.0034
192 MAGNETIC RESONANCE IMAGING ABNORMAL 4 0.0033
193 HAEMATOMA MUSCLE 4 0.0033
194 SUPERINFECTION 5 0.0033
195 SACRAL PAIN 2 0.0033
196 CATARACT SUBCAPSULAR 2 0.0033
197 PNEUMONIA KLEBSIELLA 6 0.0033
198 CEREBRAL ASPERGILLOSIS 2 0.0033
199 SMALL INTESTINAL PERFORATION 6 0.0032
200 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 4 0.0032
201 FUNGAEMIA 5 0.0032
202 WRONG SCHEDULE 3 0.0031
203 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 2 0.0031
204 PULSELESS ELECTRICAL ACTIVITY 13 0.0031
205 CYTOMEGALOVIRUS CHORIORETINITIS 6 0.0031
206 PYELONEPHRITIS ACUTE 6 0.0031
207 PSEUDOMONAS INFECTION 26 0.0030
208 INFLAMMATORY MARKER INCREASED 15 0.0030
209 EMPYEMA 6 0.0030
210 NORMOCHROMIC NORMOCYTIC ANAEMIA 9 0.0030
211 CYTOKINE STORM 2 0.0029
212 RETINAL TOXICITY 3 0.0029
213 CENTRAL NERVOUS SYSTEM LYMPHOMA 4 0.0029
214 TENOSYNOVITIS 8 0.0029
215 VIRAEMIA 4 0.0029
216 PNEUMOCYSTIS JIROVECII PNEUMONIA 29 0.0029
217 SPONDYLOLISTHESIS 5 0.0029
218 STAPHYLOCOCCAL SEPSIS 14 0.0028
219 GLASSY EYES 2 0.0028
220 POST HERPETIC NEURALGIA 4 0.0028
221 TOXOPLASMOSIS 3 0.0028
222 FINE MOTOR SKILL DYSFUNCTION 8 0.0028
223 OESOPHAGEAL CANDIDIASIS 11 0.0028
224 ASPERGILLUS INFECTION 18 0.0027
225 PANCREATIC ENZYMES INCREASED 4 0.0027
226 OTITIS MEDIA ACUTE 2 0.0027
227 CYTOMEGALOVIRUS INFECTION REACTIVATION 12 0.0027
228 HYPOSMIA 4 0.0027
229 LUNG OPACITY 7 0.0027
230 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 7 0.0026
231 MYCOPLASMA INFECTION 2 0.0026
232 IRIDOCYCLITIS 8 0.0025
233 SINUSITIS FUNGAL 2 0.0025
234 GIANT CELL ARTERITIS 2 0.0024
235 LATENT TUBERCULOSIS 5 0.0024
236 KLEBSIELLA INFECTION 12 0.0024
237 CEREBRAL VENOUS SINUS THROMBOSIS 2 0.0024
238 BRONCHIAL SECRETION RETENTION 3 0.0024
239 DEAFNESS BILATERAL 4 0.0024
240 PSEUDOMONAL BACTERAEMIA 2 0.0023
241 COLONIC ABSCESS 2 0.0023
242 CARDIAC VENTRICULAR THROMBOSIS 3 0.0023
243 PULMONARY CAVITATION 2 0.0023
244 DRUG CLEARANCE DECREASED 3 0.0023
245 MASS 32 0.0023
246 MENINGITIS CRYPTOCOCCAL 4 0.0023
247 CYTOPENIA 28 0.0023
248 HYPOGAMMAGLOBULINAEMIA 15 0.0023
249 RADICULOPATHY 6 0.0023
250 ORGANISING PNEUMONIA 11 0.0022
251 PERIPHERAL ISCHAEMIA 9 0.0022
252 INTESTINAL INFARCTION 2 0.0022
253 SOFT TISSUE INFECTION 4 0.0022
254 CULTURE URINE POSITIVE 3 0.0021
255 PULPITIS DENTAL 2 0.0021
256 ABSCESS LIMB 9 0.0021
257 RETINAL VEIN OCCLUSION 6 0.0021
258 RENAL INFARCT 3 0.0021
259 PNEUMONIA CYTOMEGALOVIRAL 4 0.0021
260 BLOOD IRON ABNORMAL 2 0.0020
261 HAEMOPHILUS INFECTION 2 0.0020
262 ENCEPHALITIS 14 0.0020
263 HIGH DENSITY LIPOPROTEIN INCREASED 2 0.0020
264 SMALL CELL LUNG CANCER 3 0.0020
265 POLYARTHRITIS 10 0.0019
266 PNEUMONIA VIRAL 6 0.0019
267 LEUKOCYTOSIS 34 0.0019
268 PNEUMONIA LEGIONELLA 3 0.0019
269 EXOPHTHALMOS 4 0.0019
270 STREPTOCOCCAL BACTERAEMIA 2 0.0018
271 LYMPHOPENIA 26 0.0018
272 DEEP VEIN THROMBOSIS 119 0.0018
273 PNEUMONIA STREPTOCOCCAL 2 0.0018
274 BRADYARRHYTHMIA 3 0.0018
275 INJECTION RELATED REACTION 3 0.0018
276 LIVER FUNCTION TEST INCREASED 39 0.0018
277 SYSTEMIC INFECTION 3 0.0018
278 ACUTE RESPIRATORY DISTRESS SYNDROME 32 0.0018
279 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 2 0.0018
280 ENTEROBACTER INFECTION 3 0.0018
281 VENOUS THROMBOSIS 7 0.0018
282 PNEUMONIA FUNGAL 7 0.0018
283 BACTERAEMIA 21 0.0018
284 ACUTE RESPIRATORY FAILURE 34 0.0018
285 HYPERSENSITIVITY PNEUMONITIS 2 0.0018
286 PULMONARY EMBOLISM 166 0.0017
287 LUNG CANCER METASTATIC 5 0.0017
288 FUNGAL SKIN INFECTION 7 0.0017
289 ADENOVIRUS INFECTION 5 0.0017
290 BLOOD TEST ABNORMAL 24 0.0017
291 PROCALCITONIN INCREASED 2 0.0017
292 LYMPHOPROLIFERATIVE DISORDER 5 0.0017
293 POLYMYOSITIS 3 0.0017
294 PNEUMONIA INFLUENZAL 2 0.0017
295 LONG QT SYNDROME 4 0.0017
296 EMBOLISM ARTERIAL 2 0.0017
297 OPHTHALMIC HERPES ZOSTER 3 0.0017
298 ENCEPHALITIS VIRAL 2 0.0016
299 JUVENILE IDIOPATHIC ARTHRITIS 4 0.0016
300 PNEUMOPERITONEUM 3 0.0016
301 OPPORTUNISTIC INFECTION 3 0.0016
302 SPINAL PAIN 19 0.0016
303 HYPERTRICHOSIS 3 0.0016
304 ESCHERICHIA INFECTION 13 0.0016
305 TUBERCULIN TEST POSITIVE 4 0.0016
306 DERMATOMYOSITIS 4 0.0016
307 MYOCARDITIS 18 0.0016
308 RHEUMATOID ARTHRITIS 178 0.0016
309 OSTEOPOROTIC FRACTURE 3 0.0016
310 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 86 0.0016
311 ENDOCARDITIS 8 0.0016
312 THERAPEUTIC PRODUCT EFFECT VARIABLE 6 0.0015
313 STAPHYLOCOCCAL INFECTION 51 0.0015
314 OCULAR HYPERTENSION 3 0.0015
315 CANDIDA INFECTION 26 0.0015
316 LUMBAR VERTEBRAL FRACTURE 7 0.0015
317 VULVOVAGINAL MYCOTIC INFECTION 6 0.0015
318 ENCEPHALITIS AUTOIMMUNE 2 0.0015
319 HERPES OPHTHALMIC 2 0.0015
320 CORONARY ARTERY THROMBOSIS 3 0.0015
321 THERAPY PARTIAL RESPONDER 23 0.0015
322 IMMUNOSUPPRESSION 13 0.0015
323 RHEUMATOID NODULE 4 0.0015
324 EMBOLISM 12 0.0014
325 DIABETIC METABOLIC DECOMPENSATION 2 0.0014
326 GASTROENTERITIS 21 0.0014
327 TORTICOLLIS 3 0.0014
328 ATYPICAL MYCOBACTERIAL INFECTION 2 0.0014
329 RETROPERITONEAL HAEMATOMA 3 0.0014
330 IMPETIGO 2 0.0013
331 METABOLIC ENCEPHALOPATHY 4 0.0013
332 LUNG ADENOCARCINOMA 4 0.0013
333 BLOOD LOSS ANAEMIA 3 0.0013
334 VASCULAR DEVICE INFECTION 6 0.0013
335 GINGIVAL HYPERTROPHY 2 0.0013
336 PARAINFLUENZAE VIRUS INFECTION 2 0.0013
337 RHINOVIRUS INFECTION 5 0.0013
338 PULMONARY INFARCTION 3 0.0013
339 VOLVULUS 3 0.0013
340 PNEUMOTHORAX 20 0.0013
341 OXYGEN CONSUMPTION INCREASED 3 0.0013
342 LOSS OF THERAPEUTIC RESPONSE 4 0.0013
343 PANNICULITIS 3 0.0012
344 HERPES SIMPLEX 8 0.0012
345 HAEMATOLOGICAL INFECTION 3 0.0012
346 DEAFNESS NEUROSENSORY 4 0.0012
347 LISTLESS 4 0.0012
348 PAPILLOMA VIRAL INFECTION 2 0.0012
349 GASTROINTESTINAL PERFORATION 5 0.0012
350 CATHETER SITE HAEMORRHAGE 3 0.0012
351 HERPES ZOSTER 68 0.0012
352 CEREBELLAR INFARCTION 2 0.0012
353 LEUKOPENIA 59 0.0012
354 HEPATITIS 30 0.0012
355 TRANSAMINASES INCREASED 26 0.0012
356 MYCOBACTERIAL INFECTION 2 0.0012
357 DEPRESSION SUICIDAL 4 0.0012
358 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
359 SPLENIC INFARCTION 2 0.0011
360 CYTOMEGALOVIRUS INFECTION 19 0.0011
361 THROMBOPHLEBITIS 4 0.0011
362 EMBOLIC STROKE 4 0.0011
363 LIMB DISCOMFORT 35 0.0011
364 CYTOMEGALOVIRUS VIRAEMIA 5 0.0011
365 FACIAL PAIN 10 0.0011
366 GINGIVITIS 6 0.0011
367 PYODERMA GANGRENOSUM 4 0.0011
368 SUSPECTED OFF LABEL USE 5 0.0011
369 INVASIVE DUCTAL BREAST CARCINOMA 3 0.0011
370 ORAL FUNGAL INFECTION 3 0.0011
371 ADENOCARCINOMA OF COLON 2 0.0011
372 STENOSIS 2 0.0011
373 HUMAN HERPESVIRUS 6 INFECTION 2 0.0011
374 HYPOPROTEINAEMIA 2 0.0011
375 PNEUMATOSIS INTESTINALIS 3 0.0011
376 PULSE ABSENT 5 0.0011
377 RESPIRATORY TRACT INFECTION 27 0.0010
378 ASPARTATE AMINOTRANSFERASE INCREASED 55 0.0010
379 ARTERIAL THROMBOSIS 2 0.0010
380 APHTHOUS ULCER 8 0.0010
381 THROMBOTIC MICROANGIOPATHY 10 0.0010
382 COVID-19 180 0.0010
383 ABDOMINAL WALL HAEMATOMA 2 0.0010
384 HYPOXIA 36 0.0010
385 RENAL CELL CARCINOMA 5 0.0010
386 LYMPHOCYTE COUNT DECREASED 18 0.0010
387 OCCULT BLOOD POSITIVE 2 0.0010
388 THORACIC VERTEBRAL FRACTURE 3 0.0010
389 ALANINE AMINOTRANSFERASE INCREASED 62 0.0010
390 THYROIDITIS 3 0.0010
391 SKIN PAPILLOMA 4 0.0010
392 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 17 0.0010
393 LIPIDS INCREASED 2 0.0010
394 RESPIRATORY DEPRESSION 12 0.0010
395 CONJUNCTIVITIS 18 0.0010
396 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
397 ATRIAL THROMBOSIS 2 0.0010
398 RESPIRATORY FAILURE 70 0.0010
399 MULTIPLE ORGAN DYSFUNCTION SYNDROME 27 0.0010
400 EAR SWELLING 2 0.0009
401 BILE DUCT STONE 3 0.0009
402 ABSCESS 15 0.0009
403 PULMONARY TUBERCULOSIS 4 0.0009
404 BACTERIAL SEPSIS 3 0.0009
405 CERVICAL DYSPLASIA 2 0.0009
406 OTITIS MEDIA 3 0.0009
407 NOSOCOMIAL INFECTION 2 0.0009
408 SKIN MASS 6 0.0009
409 TREATMENT FAILURE 74 0.0009
410 GASTROINTESTINAL INFECTION 8 0.0009
411 INTESTINAL PERFORATION 10 0.0009
412 DIVERTICULUM INTESTINAL HAEMORRHAGIC 2 0.0009
413 BK VIRUS INFECTION 3 0.0009
414 CHRONIC GASTRITIS 2 0.0009
415 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
416 PERIARTHRITIS 2 0.0009
417 SEPTIC SHOCK 38 0.0009
418 RHINITIS 7 0.0009
419 RESPIRATORY TRACT INFECTION VIRAL 2 0.0009
420 BACTERIAL INFECTION 16 0.0009
421 RIGHT VENTRICULAR FAILURE 6 0.0009
422 TIBIA FRACTURE 4 0.0009
423 SUDDEN DEATH 9 0.0008
424 CLOSTRIDIUM DIFFICILE COLITIS 9 0.0008
425 LACUNAR INFARCTION 2 0.0008
426 CHRONIC GRAFT VERSUS HOST DISEASE 3 0.0008
427 DIABETES INSIPIDUS 2 0.0008
428 RETROPERITONEAL HAEMORRHAGE 2 0.0008
429 DISABILITY 16 0.0008
430 PYELONEPHRITIS 7 0.0008
431 SKIN INFECTION 9 0.0008
432 LUNG INFILTRATION 7 0.0008
433 BLOOD TRIGLYCERIDES INCREASED 14 0.0008
434 ISCHAEMIC STROKE 14 0.0008
435 EPIGASTRIC DISCOMFORT 3 0.0008
436 HEPATITIS TOXIC 2 0.0008
437 PLATELET COUNT INCREASED 10 0.0008
438 CARDIOGENIC SHOCK 11 0.0008
439 RESPIRATORY ACIDOSIS 3 0.0008
440 UROSEPSIS 7 0.0008
441 SPINAL FRACTURE 15 0.0007
442 ATRIOVENTRICULAR BLOCK COMPLETE 5 0.0007
443 ACUTE MYOCARDIAL INFARCTION 22 0.0007
444 SQUAMOUS CELL CARCINOMA 7 0.0007
445 BRONCHIECTASIS 5 0.0007
446 ARTHRITIS 58 0.0007
447 HAEMATOTOXICITY 7 0.0007
448 DEMYELINATION 3 0.0007
449 ARTHRITIS BACTERIAL 3 0.0007
450 SUBDURAL HAEMORRHAGE 2 0.0007
451 PULMONARY FIBROSIS 14 0.0007
452 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0007
453 LARGE INTESTINE PERFORATION 5 0.0007
454 HYPERTENSIVE CRISIS 8 0.0007
455 STREPTOCOCCAL INFECTION 4 0.0007
456 C-REACTIVE PROTEIN INCREASED 26 0.0007
457 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
458 MYOPATHY 6 0.0007
459 HERPES VIRUS INFECTION 4 0.0007
460 MOUTH SWELLING 4 0.0007
461 PULMONARY PAIN 2 0.0007
462 MELAENA 15 0.0007
463 CEREBRAL DISORDER 5 0.0007
464 BRAIN HERNIATION 2 0.0007
465 THERAPY NON-RESPONDER 30 0.0007
466 OPTIC NEURITIS 6 0.0007
467 ADRENAL INSUFFICIENCY 8 0.0007
468 OXYGEN SATURATION DECREASED 37 0.0007
469 DISEASE COMPLICATION 3 0.0007
470 DIFFUSE LARGE B-CELL LYMPHOMA 5 0.0006
471 CYTOKINE RELEASE SYNDROME 13 0.0006
472 HYPOMAGNESAEMIA 9 0.0006
473 EPSTEIN-BARR VIRUS INFECTION 4 0.0006
474 BLOOD BLISTER 2 0.0006
475 VAGINAL INFECTION 3 0.0006
476 SKIN ABRASION 3 0.0006
477 BREAST CANCER RECURRENT 2 0.0006
478 RED BLOOD CELL SEDIMENTATION RATE INCREASED 7 0.0006
479 HEPATITIS B REACTIVATION 2 0.0006
480 RENAL CYST 5 0.0006
481 NON-SMALL CELL LUNG CANCER 3 0.0006
482 BLOOD DISORDER 5 0.0006
483 C-REACTIVE PROTEIN ABNORMAL 4 0.0006
484 CUSHINGOID 2 0.0006
485 ENTEROCOCCAL INFECTION 3 0.0006
486 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 18 0.0006
487 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
488 CEREBRAL INFARCTION 15 0.0006
489 OSTEOARTHRITIS 26 0.0006
490 CORONAVIRUS INFECTION 4 0.0006
491 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 2 0.0006
492 INTERSTITIAL LUNG DISEASE 29 0.0006
493 NEPHRITIS 2 0.0006
494 OSTEOPENIA 9 0.0006
495 FACIAL PARALYSIS 5 0.0006
496 GRANULOMA 2 0.0006
497 BURSITIS 7 0.0006
498 ARTHROPATHY 32 0.0006
499 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
500 HYPERTRANSAMINASAEMIA 4 0.0006
501 NECROTISING FASCIITIS 2 0.0006
502 BONE EROSION 2 0.0006
503 EYE PRURITUS 19 0.0006
504 PULMONARY THROMBOSIS 6 0.0005
505 CAROTID ARTERY OCCLUSION 2 0.0005
506 HYPERKERATOSIS 3 0.0005
507 RESPIRATORY DISTRESS 15 0.0005
508 BONE DENSITY ABNORMAL 2 0.0005
509 RESPIRATORY DISORDER 16 0.0005
510 PERITONITIS 11 0.0005
511 ACUTE KIDNEY INJURY 81 0.0005
512 HYPOCALCAEMIA 10 0.0005
513 OFF LABEL USE 462 0.0005
514 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
515 DEVICE RELATED INFECTION 8 0.0005
516 TACHYPNOEA 7 0.0005
517 EOSINOPHILIA 9 0.0005
518 CERVIX CARCINOMA 2 0.0005
519 EYE SWELLING 19 0.0005
520 AFFECTIVE DISORDER 4 0.0005
521 LYMPHADENOPATHY 18 0.0005
522 MYOCLONUS 6 0.0005
523 ENDOPHTHALMITIS 3 0.0005
524 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
525 ACUTE CORONARY SYNDROME 4 0.0005
526 CARDIO-RESPIRATORY ARREST 20 0.0005
527 CARDIAC ARREST 39 0.0005
528 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
529 IMMUNODEFICIENCY 7 0.0005
530 HEPATIC LESION 2 0.0005
531 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
532 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
533 ONYCHOMYCOSIS 2 0.0005
534 SARS-COV-2 TEST POSITIVE 6 0.0005
535 ABDOMINAL ABSCESS 2 0.0005
536 SEPSIS 50 0.0004
537 DRUG-INDUCED LIVER INJURY 14 0.0004
538 POSTOPERATIVE WOUND INFECTION 3 0.0004
539 SYNOVITIS 8 0.0004
540 PATHOGEN RESISTANCE 4 0.0004
541 PNEUMONIA 142 0.0004
542 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
543 SHOCK 10 0.0004
544 OVARIAN CANCER 4 0.0004
545 DIVERTICULITIS 12 0.0004
546 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
547 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
548 ARTHRITIS INFECTIVE 2 0.0004
549 APPENDICITIS 4 0.0004
550 SPLENOMEGALY 5 0.0004
551 PAPULE 3 0.0004
552 RASH VESICULAR 2 0.0004
553 CONDITION AGGRAVATED 125 0.0004
554 HEPATIC ENZYME ABNORMAL 2 0.0004
555 HEPATOCELLULAR CARCINOMA 3 0.0004
556 AORTIC ANEURYSM 3 0.0004
557 PSORIATIC ARTHROPATHY 16 0.0004
558 PLATELET COUNT DECREASED 42 0.0004
559 TACHYCARDIA 35 0.0004
560 HAEMODYNAMIC INSTABILITY 3 0.0004
561 FEMORAL NECK FRACTURE 2 0.0004
562 RIB FRACTURE 8 0.0004
563 TRANSFUSION 4 0.0004
564 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 27 0.0004
565 SERUM FERRITIN INCREASED 2 0.0004
566 QUALITY OF LIFE DECREASED 5 0.0004
567 BEHAVIOUR DISORDER 2 0.0004
568 SHOCK HAEMORRHAGIC 3 0.0004
569 LIVER INJURY 9 0.0004
570 PERIPHERAL COLDNESS 5 0.0004
571 SPINAL COMPRESSION FRACTURE 3 0.0004
572 INFECTION 52 0.0004
573 ORAL HERPES 7 0.0004
574 PERICARDITIS 6 0.0004
575 MACULAR OEDEMA 2 0.0004
576 HYPERGLYCAEMIA 13 0.0004
577 HEMIPARESIS 6 0.0004
578 STATUS EPILEPTICUS 4 0.0004
579 REBOUND EFFECT 4 0.0004
580 CHOLECYSTITIS ACUTE 2 0.0004
581 NEUTROPHILIA 2 0.0004
582 NEUROLOGICAL SYMPTOM 2 0.0003
583 UPPER RESPIRATORY TRACT INFECTION 16 0.0003
584 DELIRIUM 12 0.0003
585 FEEDING DISORDER 7 0.0003
586 RESPIRATORY RATE INCREASED 3 0.0003
587 CELLULITIS 17 0.0003
588 PLEURISY 2 0.0003
589 PULMONARY MASS 5 0.0003
590 MYOSITIS 3 0.0003
591 THERAPY CESSATION 17 0.0003
592 SKIN DISORDER 11 0.0003
593 NEOPLASM MALIGNANT 22 0.0003
594 HIDRADENITIS 3 0.0003
595 LUNG DISORDER 16 0.0003
596 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 17 0.0003
597 LYMPHOMA 5 0.0003
598 CHOLANGITIS 2 0.0003
599 BRADYCARDIA 17 0.0003
600 PHOTOPHOBIA 6 0.0003
601 DERMATITIS ALLERGIC 4 0.0003
602 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
603 DRUG RESISTANCE 8 0.0003
604 SINUS BRADYCARDIA 3 0.0003
605 NODULE 4 0.0003
606 METASTASES TO BONE 5 0.0003
607 WHITE BLOOD CELL COUNT DECREASED 33 0.0003
608 ORAL CANDIDIASIS 4 0.0003
609 HOSPICE CARE 3 0.0003
610 PERICARDIAL EFFUSION 7 0.0003
611 CARDIAC FAILURE ACUTE 2 0.0003
612 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
613 VAGINAL DISCHARGE 3 0.0003
614 METASTASES TO LYMPH NODES 2 0.0003
615 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
616 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
617 METASTASES TO LIVER 5 0.0003
618 DUODENAL ULCER 2 0.0003
619 DRUG ERUPTION 5 0.0003
620 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
621 DIVERTICULUM 2 0.0003
622 PNEUMONIA ASPIRATION 7 0.0003
623 DECREASED ACTIVITY 3 0.0003
624 CARDIOVASCULAR DISORDER 7 0.0003
625 APATHY 4 0.0003
626 URINARY TRACT INFECTION 46 0.0003
627 OSTEOPOROSIS 11 0.0003
628 MUCOSAL INFLAMMATION 7 0.0003
629 HYDRONEPHROSIS 2 0.0003
630 ABDOMINAL PAIN 62 0.0003
631 DRUG INEFFECTIVE 349 0.0003
632 HEPATIC ENZYME INCREASED 18 0.0003
633 MUSCULAR WEAKNESS 30 0.0003
634 LOWER RESPIRATORY TRACT INFECTION 12 0.0003
635 HAEMOGLOBIN DECREASED 27 0.0003
636 METASTASES TO LUNG 3 0.0003
637 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
638 PELVIC FRACTURE 2 0.0003
639 BASAL CELL CARCINOMA 4 0.0003
640 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
641 FURUNCLE 2 0.0003
642 MENTAL STATUS CHANGES 7 0.0003
643 HYPERLIPIDAEMIA 3 0.0003
644 NERVOUSNESS 13 0.0002
645 DECUBITUS ULCER 2 0.0002
646 ENCEPHALOPATHY 6 0.0002
647 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
648 HEPATIC FUNCTION ABNORMAL 9 0.0002
649 LIP SWELLING 8 0.0002
650 FUNGAL INFECTION 8 0.0002
651 LIVE BIRTH 2 0.0002
652 HAEMODIALYSIS 2 0.0002
653 RENAL IMPAIRMENT 20 0.0002
654 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
655 SKIN PLAQUE 2 0.0002
656 CARDIAC FAILURE 19 0.0002
657 DISEASE PROGRESSION 28 0.0002
658 THROMBOSIS 19 0.0002
659 HEPATIC CYTOLYSIS 3 0.0002
660 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
661 HIATUS HERNIA 3 0.0002
662 HAEMATOMA 6 0.0002
663 PLEURAL EFFUSION 14 0.0002
664 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
665 DEAFNESS 6 0.0002
666 HYPERKALAEMIA 8 0.0002
667 BLOOD CALCIUM INCREASED 2 0.0002
668 IMMUNE SYSTEM DISORDER 3 0.0002
669 HYPOGLYCAEMIA 11 0.0002
670 HAEMOLYTIC ANAEMIA 2 0.0002
671 HEAVY MENSTRUAL BLEEDING 2 0.0002
672 UVEITIS 3 0.0002
673 GASTROINTESTINAL CARCINOMA 2 0.0002
674 TOXICITY TO VARIOUS AGENTS 37 0.0002
675 WEIGHT INCREASED 49 0.0002
676 SKIN DISCOLOURATION 10 0.0002
677 ATRIAL FIBRILLATION 21 0.0002
678 HEPATIC STEATOSIS 4 0.0002
679 PANCYTOPENIA 12 0.0002
680 SKIN REACTION 3 0.0002
681 SPINAL DISORDER 2 0.0002
682 OCULAR HYPERAEMIA 10 0.0002
683 DISEASE RECURRENCE 10 0.0002
684 POST PROCEDURAL COMPLICATION 4 0.0002
685 HYPERCHOLESTEROLAEMIA 2 0.0002
686 ATELECTASIS 2 0.0002
687 HAEMORRHOIDS 4 0.0002
688 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
689 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
690 HAEMATOCRIT DECREASED 4 0.0002
691 ILL-DEFINED DISORDER 12 0.0002
692 NECK PAIN 11 0.0002
693 DISCOMFORT 12 0.0002
694 SUBARACHNOID HAEMORRHAGE 2 0.0002
695 ANKLE FRACTURE 3 0.0002
696 TENDONITIS 3 0.0002
697 RHABDOMYOLYSIS 8 0.0002
698 FOLLICULITIS 2 0.0002
699 MOUTH ULCERATION 4 0.0002
700 PRODUCT USE IN UNAPPROVED INDICATION 47 0.0002
701 BLOOD BILIRUBIN INCREASED 5 0.0002
702 BLOOD CREATININE INCREASED 12 0.0002
703 PRODUCT PRESCRIBING ISSUE 4 0.0002
704 VENTRICULAR TACHYCARDIA 3 0.0002
705 GENERAL PHYSICAL HEALTH DETERIORATION 21 0.0002
706 DRUG LEVEL INCREASED 3 0.0002
707 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
708 FOOT DEFORMITY 2 0.0002
709 TOOTH DISORDER 4 0.0002
710 MITRAL VALVE INCOMPETENCE 2 0.0002
711 PERIPHERAL SWELLING 27 0.0002
712 PANCREATIC CARCINOMA 5 0.0002
713 ELECTROLYTE IMBALANCE 2 0.0002
714 BLOOD CHOLESTEROL INCREASED 8 0.0002
715 MUSCULOSKELETAL STIFFNESS 15 0.0002
716 COUGH 48 0.0002
717 LUNG NEOPLASM MALIGNANT 7 0.0002
718 THROMBOCYTOPENIA 19 0.0002
719 CHOLECYSTITIS 2 0.0002
720 ANAEMIA 32 0.0002
721 GASTROINTESTINAL DISORDER 15 0.0002
722 HEPATIC FAILURE 5 0.0002
723 HEPATITIS C 2 0.0002
724 FIBROMYALGIA 4 0.0002
725 NEURALGIA 4 0.0002
726 DRUG INTERACTION 26 0.0002
727 SMALL INTESTINAL OBSTRUCTION 2 0.0002
728 HYPERCALCAEMIA 2 0.0002
729 FEMUR FRACTURE 5 0.0002
730 PHARYNGITIS 2 0.0002
731 BREAST CANCER 15 0.0002
732 ILEUS 2 0.0002
733 SECRETION DISCHARGE 2 0.0002
734 HYPOTENSION 32 0.0002
735 FRACTURE 3 0.0002
736 LIVER DISORDER 7 0.0002
737 CYSTITIS 5 0.0002
738 HYPOTHYROIDISM 5 0.0002
739 METABOLIC ACIDOSIS 5 0.0002
740 MOVEMENT DISORDER 5 0.0002
741 INFLAMMATION 8 0.0002
742 SKIN ULCER 4 0.0002
743 BONE PAIN 9 0.0002
744 KIDNEY INFECTION 3 0.0002
745 JOINT STIFFNESS 4 0.0002
746 OSTEONECROSIS 5 0.0002
747 GASTRITIS 4 0.0002
748 VIRAL INFECTION 5 0.0002
749 URINARY RETENTION 5 0.0001
750 INTENTIONAL PRODUCT USE ISSUE 13 0.0001
751 EXTRA DOSE ADMINISTERED 6 0.0001
752 PYREXIA 51 0.0001
753 BODY TEMPERATURE INCREASED 3 0.0001
754 PALLOR 4 0.0001
755 PNEUMONITIS 4 0.0001
756 MATERNAL EXPOSURE DURING PREGNANCY 13 0.0001
757 ILLNESS 15 0.0001
758 UNEVALUABLE EVENT 11 0.0001
759 ANAPHYLACTIC REACTION 8 0.0001
760 TOOTH LOSS 3 0.0001
761 PULMONARY HYPERTENSION 3 0.0001
762 HAEMOPTYSIS 4 0.0001
763 CARPAL TUNNEL SYNDROME 2 0.0001
764 PAIN IN EXTREMITY 42 0.0001
765 KNEE ARTHROPLASTY 3 0.0001
766 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
767 EYE PAIN 8 0.0001
768 CEREBROVASCULAR ACCIDENT 24 0.0001
769 IRRITABLE BOWEL SYNDROME 3 0.0001
770 SKIN CANCER 3 0.0001
771 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
772 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
773 FAECES DISCOLOURED 3 0.0001
774 HYPOKINESIA 2 0.0001
775 LIVER FUNCTION TEST ABNORMAL 4 0.0001
776 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
777 HYPERTENSION 29 0.0001
778 SINUSITIS 14 0.0001
779 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
780 COLON CANCER 2 0.0001
781 EPISTAXIS 10 0.0001
782 SPEECH DISORDER 7 0.0001
783 PANCREATITIS ACUTE 3 0.0001
784 CORONARY ARTERY DISEASE 4 0.0001
785 INJECTION SITE REACTION 9 0.0001
786 HIP ARTHROPLASTY 2 0.0001
787 VOMITING 61 0.0001
788 LUNG INFECTION 2 0.0001
789 EXPOSURE DURING PREGNANCY 8 0.0001
790 BALANCE DISORDER 11 0.0001
791 CYANOSIS 2 0.0001
792 ARRHYTHMIA 6 0.0001
793 PRODUCT PRESCRIBING ERROR 3 0.0001
794 INFLUENZA 14 0.0001
795 OBESITY 2 0.0001
796 MOBILITY DECREASED 9 0.0001
797 BLISTER 7 0.0001
798 JOINT SWELLING 15 0.0001
799 DRUG INTOLERANCE 12 0.0001
800 CHEST PAIN 23 0.0001
801 PRESYNCOPE 3 0.0001
802 IMPAIRED HEALING 4 0.0001
803 PHOTOSENSITIVITY REACTION 2 0.0001
804 INFUSION RELATED REACTION 8 0.0001
805 ARTHRALGIA 50 0.0001
806 COAGULOPATHY 2 0.0001
807 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
808 ABDOMINAL PAIN LOWER 3 0.0001
809 DEATH 102 0.0001
810 CATARACT 7 0.0001
811 SWELLING 11 0.0001
812 HYPOPHAGIA 3 0.0001
813 HAEMATURIA 4 0.0001
814 UNRESPONSIVE TO STIMULI 3 0.0001
815 MUSCULOSKELETAL DISCOMFORT 2 0.0001
816 PSORIASIS 15 0.0001
817 PANCREATITIS 6 0.0001
818 COLD SWEAT 2 0.0001
819 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
820 RENAL FAILURE 15 0.0001
821 MYALGIA 19 0.0001
822 CEREBRAL HAEMORRHAGE 4 0.0001
823 PULMONARY OEDEMA 5 0.0001
824 HEADACHE 70 0.0001
825 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 20 0.0001
826 THROAT TIGHTNESS 3 0.0001
827 FOETAL EXPOSURE DURING PREGNANCY 9 0.0001
828 OSTEOMYELITIS 2 0.0001
829 SKIN LESION 3 0.0001
830 TINNITUS 5 0.0001
831 HAEMATOCHEZIA 6 0.0001
832 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
833 SWELLING FACE 7 0.0001
834 BLOOD URINE PRESENT 2 0.0001
835 BLOOD PRESSURE DECREASED 7 0.0001
836 ANGINA PECTORIS 3 0.0001
837 LOWER LIMB FRACTURE 2 0.0001
838 PRESCRIBED OVERDOSE 2 0.0001
839 RASH 45 0.0001
840 NEUTROPENIA 14 0.0001
841 EAR PAIN 2 0.0001
842 DYSSTASIA 3 0.0001
843 DYSPNOEA 57 0.0001
844 SYNCOPE 10 0.0001
845 APHASIA 3 0.0001
846 SLEEP DISORDER 7 0.0001
847 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
848 THERAPEUTIC RESPONSE DECREASED 6 0.0001
849 BRONCHITIS 7 0.0001
850 MOOD SWINGS 3 0.0001
851 GAIT DISTURBANCE 18 0.0001
852 POOR QUALITY SLEEP 2 0.0001
853 OVERDOSE 20 0.0001
854 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
855 PRODUCT DISPENSING ERROR 2 0.0001
856 DIARRHOEA 59 0.0001
857 EYE DISORDER 3 0.0001
858 RASH MACULO-PAPULAR 2 0.0001
859 HEPATOTOXICITY 2 0.0001
860 GAIT INABILITY 3 0.0001
861 NAUSEA 71 0.0001
862 MUSCLE SPASMS 16 0.0001
863 ADVERSE EVENT 8 0.0001
864 MUSCLE TWITCHING 2 0.0001
865 ALOPECIA 17 0.0001
866 OROPHARYNGEAL PAIN 8 0.0001
867 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
868 DYSPHAGIA 8 0.0001
869 COMA 4 0.0001
870 RASH ERYTHEMATOUS 4 0.0001
871 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
872 CONTUSION 8 0.0001
873 ERYTHEMA 17 0.0001
874 LOCALISED INFECTION 2 0.0001
875 OEDEMA PERIPHERAL 10 0.0001
876 INJECTION SITE URTICARIA 2 0.0001
877 DYSURIA 3 0.0001
878 OSTEONECROSIS OF JAW 2 0.0001
879 MEMORY IMPAIRMENT 11 0.0001
880 DYSARTHRIA 3 0.0001
881 COLITIS 3 0.0001
882 HAEMATEMESIS 2 0.0001
883 ABDOMINAL DISCOMFORT 13 0.0001
884 ECZEMA 4 0.0001
885 SEDATION 2 0.0001
886 DERMATITIS ATOPIC 4 0.0001
887 ABORTION SPONTANEOUS 3 0.0001
888 CARDIAC DISORDER 7 0.0001
889 DEPRESSION 17 0.0001
890 FEAR 2 0.0001
891 RASH PRURITIC 4 0.0001
892 BLINDNESS 3 0.0001
893 NEUTROPHIL COUNT DECREASED 3 0.0001
894 MOOD ALTERED 2 0.0001
895 VISION BLURRED 10 0.0001
896 RESPIRATORY ARREST 2 0.0001
897 MEDICATION ERROR 4 0.0001
898 FEELING COLD 2 0.0001
899 DEMENTIA 2 0.0001
900 HEART RATE INCREASED 7 0.0001
901 THERAPY INTERRUPTED 5 0.0001
902 VAGINAL HAEMORRHAGE 3 0.0001
903 DECREASED APPETITE 16 0.0001
904 WHEEZING 4 0.0001
905 FATIGUE 52 0.0001
906 NO ADVERSE EVENT 12 0.0001
907 PAIN 40 0.0001
908 BACK PAIN 15 0.0001
909 RENAL DISORDER 3 0.0001
910 BONE DENSITY DECREASED 2 0.0001
911 RENAL CANCER 3 0.0001
912 HIP FRACTURE 2 0.0001
913 NIGHT SWEATS 2 0.0001
914 LACTIC ACIDOSIS 2 0.0001
915 FEBRILE NEUTROPENIA 4 0.0001
916 DRY SKIN 8 0.0001
917 PRURITUS 23 0.0001
918 SKIN EXFOLIATION 5 0.0001
919 GASTRIC DISORDER 2 0.0001
920 WEIGHT DECREASED 16 0.0001
921 MUSCULOSKELETAL PAIN 3 0.0001
922 CONFUSIONAL STATE 9 0.0001
923 MYELOSUPPRESSION 2 0.0001
924 CRYING 2 0.0001
925 PANIC ATTACK 2 0.0001
926 MALAISE 24 0.0001
927 ACCIDENTAL OVERDOSE 2 0.0001
928 TREMOR 9 0.0001
929 DYSPNOEA EXERTIONAL 2 0.0001
930 ASTHMA 6 0.0001
931 ANXIETY 15 0.0001
932 CHRONIC KIDNEY DISEASE 4 0.0001
933 LETHARGY 3 0.0001
934 SEIZURE 6 0.0001
935 MYOCARDIAL INFARCTION 9 0.0001
936 PALPITATIONS 6 0.0001
937 FALL 17 0.0001
938 DYSPEPSIA 5 0.0001
939 NASOPHARYNGITIS 9 0.0000
940 HYPERSENSITIVITY 9 0.0000
941 DIZZINESS 24 0.0000
942 POLLAKIURIA 2 0.0000
943 ABDOMINAL DISTENSION 5 0.0000
944 ASTHENIA 18 0.0000
945 RECTAL HAEMORRHAGE 2 0.0000
946 HYPOACUSIS 2 0.0000
947 BLOOD PRESSURE INCREASED 7 0.0000
948 INSOMNIA 12 0.0000
949 PARAESTHESIA 7 0.0000
950 BURNING SENSATION 3 0.0000
951 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
952 AGITATION 3 0.0000
953 VISUAL IMPAIRMENT 5 0.0000
954 ACNE 3 0.0000
955 DIABETES MELLITUS 3 0.0000
956 HOSPITALISATION 6 0.0000
957 LOSS OF CONSCIOUSNESS 5 0.0000
958 FEELING ABNORMAL 9 0.0000
959 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
960 OEDEMA 2 0.0000
961 CONSTIPATION 8 0.0000
962 DRUG ABUSE 3 0.0000
963 HYPONATRAEMIA 2 0.0000
964 SOMNOLENCE 7 0.0000
965 CHILLS 4 0.0000
966 NASAL CONGESTION 2 0.0000
967 BLADDER CANCER 2 0.0000
968 STOMATITIS 2 0.0000
969 FEELING HOT 2 0.0000
970 RHINORRHOEA 2 0.0000
971 AMNESIA 2 0.0000
972 CHEST DISCOMFORT 3 0.0000
973 HAEMORRHAGE 3 0.0000
974 DYSGEUSIA 2 0.0000
975 PROSTATE CANCER 2 0.0000
976 INFLUENZA LIKE ILLNESS 2 0.0000
977 ABDOMINAL PAIN UPPER 5 0.0000
978 ADVERSE DRUG REACTION 2 0.0000
979 INCORRECT DOSE ADMINISTERED 5 0.0000
980 PRODUCT USE ISSUE 4 0.0000
981 NEUROPATHY PERIPHERAL 2 0.0000
982 MIGRAINE 2 0.0000
983 EMOTIONAL DISTRESS 2 0.0000
984 BLOOD GLUCOSE INCREASED 3 0.0000
985 HYPERHIDROSIS 2 0.0000
986 PRODUCT DOSE OMISSION ISSUE 4 0.0000